Document Detail


Cortisol in physiological concentrations acts within minutes to modify effects of prolactin and growth hormone on prostaglandin secretion: importance of effect in modulating cellular responses to calcium and cyclic nucleotides.
MedLine Citation:
PMID:  967066     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
We propose that intracellular prostaglandins (PGs) are essential for the final expression of the effects of second messengers in most cells. We suggest that the amounts of PGs required are very small (in the picomolar range) and are much lower than those used in most current PG studies. We suggest that while therapeutic levels of inhibitors of PG synthetase may be adequate to block the overflow of PGs from cells, they are in most cases unlikely to reduce intracellular PGs sufficiently to test the role of such PGs. We propose that there is a basal level of PG synthesis unaffected by hormones but that above this level PG synthesis is regulated by the interplay between physiological levels of cortisol, prolactin, growth hormone and thyroid hormones. For the most part prolactin seems to stimulate PG synthesis and cortisol to inhibit it: cortisol has, however, no inhibitory effect on basal PG synthesis. In reducing prolactin-stimulated PG synthesis cortisol is 1000-2000 times more potent than indomethacin on a molar basis. We suggest that the regulation of intracellular PG levels is the mechanism of the so-called "permissive" actions of these hormones. These concepts could prove important in the understanding of many aspects of physiology and pathophysiology including diurnal and seasonal changes in hormone responsiveness. They are also relevant to the use of established drugs and the design of new ones.
Authors:
D F Horrobin; J P Mtabaji; M S Manku
Related Documents :
17072036 - Concentration of endothelin in plasma and balf fluid from asthmatic patients.
2076576 - Enhancing effects of myristyl lactate and lauryl lactate on percutaneous absorption of ...
20070396 - Serum hgf and tgf-beta1 levels after right portal vein embolization.
1737726 - In-vivo and in-vitro studies on the effect of amphotericin b on endothelin release.
5787986 - Renin-aldosterone system in parkinson's disease.
25103076 - Volume changes in remnant thyroid tissue after thyroidectomy in graves disease.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Medical hypotheses     Volume:  2     ISSN:  0306-9877     ISO Abbreviation:  Med. Hypotheses     Publication Date:    1976 Sep-Oct
Date Detail:
Created Date:  1976-11-21     Completed Date:  1976-11-21     Revised Date:  2003-11-14    
Medline Journal Info:
Nlm Unique ID:  7505668     Medline TA:  Med Hypotheses     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  219-26     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Calcium / physiology
Circadian Rhythm
Growth Hormone / physiology*
Hydrocortisone / physiology*
Lithium / pharmacology
Mesenteric Arteries / drug effects
Models, Biological
Nucleotides, Cyclic / physiology
Prolactin / physiology*
Prostaglandins / biosynthesis,  physiology*
Rats
Vasoconstrictor Agents / pharmacology
Chemical
Reg. No./Substance:
0/Nucleotides, Cyclic; 0/Prostaglandins; 0/Vasoconstrictor Agents; 50-23-7/Hydrocortisone; 7439-93-2/Lithium; 7440-70-2/Calcium; 9002-62-4/Prolactin; 9002-72-6/Growth Hormone

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  On the potential usefulness of exchange plasmapheresis in the immunotherapy of cancer and of some ch...
Next Document:  "Basal" palmar skin potentials and body fluid potassium.